• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arcellx, Inc. - Common Stock (NQ:ACLX)

68.51 -0.04 (-0.06%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Arcellx, Inc. - Common Stock

News headline image
Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings
January 21, 2026
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
December 06, 2025
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx to Host Investor Relations Event During the 67th ASH Annual Meeting and Exposition
November 18, 2025
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx Provides Third Quarter 2025 Financial Results
November 05, 2025
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx to Present New Data for Its iMMagine-1 Study and Continues Scientific Momentum with Multiple Presentations at the 67th ASH Annual Meeting and Exposition
November 03, 2025
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx to Participate at the 2025 Morgan Stanley Global Healthcare Conference
September 03, 2025
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights
August 07, 2025
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx Announces Its Participation at TD Cowen’s 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025
May 21, 2025
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
May 14, 2025
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx Provides First Quarter 2025 Financial Results and Business Highlights
May 08, 2025
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors
March 20, 2025
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx Provides Fourth Quarter and Year-End 2024 Financial Results and Business Highlights
February 27, 2025
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx to Participate at the TD Cowen 45th Annual Health Care Conference
February 26, 2025
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exposition
December 08, 2024
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights
November 07, 2024
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx to Present Clinical Data for Its Phase 1 and iMMagine-1 Studies in Patients with Relapsed or Refractory Multiple Myeloma at the 66th ASH Annual Meeting and Exposition and Announces Progress in iMMagine-3 Study
November 05, 2024
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx Provides Second Quarter 2024 Financial Results and Business Updates
August 08, 2024
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
May 09, 2024
From Arcellx, Inc.
Via Business Wire
News headline image
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
May 09, 2024
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Arcellx Provides First Quarter 2024 Financial Results
May 09, 2024
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx to Participate in Two Upcoming Investor Conferences
May 07, 2024
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 04, 2024
From Arcellx, Inc.
Via Business Wire
News headline image
Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 20, 2024
From Arcellx, Inc.
Via Business Wire
News headline image
Kite and Arcellx Announce Expansion in Strategic Partnership
November 15, 2023
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Kite and Arcellx Close Agreement to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma
January 30, 2023
From Gilead Sciences, Inc. and Arcellx, Inc.
Via Business Wire
News headline image
Kite and Arcellx Announce Strategic Collaboration to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma
December 09, 2022
From Gilead Sciences, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap